High Thyrocalcitonin Serum Level in Neuroendocrine Tumors: Characteristics, Prognosis and Interest in Follow-Up?

#1081

Introduction: Thyrocalcitonin (TCT) is usually associated with medullary thyroid cancer. However, some neuroendocrine tumors (NETs) have also high serum TCT levels.

Aim(s): The aims of this retrospective study were to assess a) characteristics and prognosis for NETs producing TCT, and b) if this marker is useful for the follow-up of these tumors.

Materials and methods: All patients with NETs and whose serum TCT was determined between 2010 and 2012 were included. Clinical, biological, and histological characteristics were studied. Previous determinations of TCT were checked in patients with high TCT, defined as TCT>100ng/L, and their levels were compared with biological and morphological follow-up.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Nozière C, Chardon L, Lombard-Bohas C, Goichot B, Hervieu V,

Keywords: thyrocalcitonin,